Novel Design Strategy for Checkpoint Kinase 2 Inhibitors Using Pharmacophore Modeling, Combinatorial Fusion, and Virtual Screening

Figure 4

The workflow of database screening and molecular docking approach for new Chk2 inhibitor candidates.